Skip to the page

Data / Form D filings / SpyGlassPharma, Inc.

SpyGlassPharma, Inc.: Form D filings

SpyGlassPharma, Inc., a health care company in Aliso Viejo, CA, filed 4 Form D notices with the SEC between 2019 and 2025. The latest, on June 5, 2025, reports $75 million sold of a $75 million offering to 10 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
27061 Aliso Creek Road, SUITE 100, Aliso Viejo, CA, 92656
Phone
(949) 284-6904
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1778922

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jun 5, 2025New notice$74,999,989$74,999,98910May 30, 2025sec.gov
Jul 11, 2023New notice$90,019,986$40,009,993$50,009,9937Jul 6, 2023sec.gov
Jan 5, 2021New notice$37,499,996$13,749,996$23,750,0004Dec 29, 2020sec.gov
Jun 5, 2019New notice$6,032,351$6,032,3512May 22, 2019sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Jake MerrillDirector
Malik KahookExecutive Officer, Director
Geoff PardoDirector
Bilal KhanDirector
Cynthia YeeDirector
Roger ZhangDirector
Patrick MooneyExecutive Officer, Director
Ali BehbahaniDirector
Zach ScheinerDirector

Other health care companies in California that filed recently

Every Form D from the week of Jun 2, 2025 · All recent filings in California · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what SpyGlassPharma, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.